Clinical Trial

Correlation Between TILs and Blood Cell Counts in Triple Negative Breast Cancer Patients

Study acronym: PERCEPTION
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
The PERCEPTION study aims to assess the correlation between blood cell counts (Leucocytes, Neutrophils, Lymphocytes, Platelets, NLR (Neutrophil-to-Lymphocyte Ratio) and PLR (Platelet-to-Lymphocyte Ratio)) and Tumor Infiltrating Lymphocytes (TILs), at baseline and after surgery, for patients diagnosed with triple negative breast cancer. It also aims to assess these circulating elements and circulating tumor DNA as predictive factor of metastatic recurrence in triple negative breast cancer.
Protocol Amendment History 7 amendments
This ClinicalTrials.gov record has been amended 7 times since 2019-08-22; most recent amendment 2026-03-18.
Status change: Recruiting → Active, Not Recruiting 2026-03-18
Status change: Not Yet Recruiting → Recruiting 2019-12-04
Trial Details
NCT Number NCT04068623
Lead Sponsor Centre Jean Perrin
Conditions Triple Negative Breast Cancer
Enrollment 90 participants
Start Date 2019-12-04
Primary Completion 2027-10 (estimated)
Study Completion 2032-10 (estimated)
Updated on ClinicalTrials.gov 2026-03-20